P44 Gene PCR Marker for Early Anaplasmosis Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing anaplasmosis, such as culturing A. phagocytophilum and serological tests, are time-consuming and prone to false positives, with low sensitivity and accuracy, especially for early detection.
Innovation Solution
Utilizing the P44 gene as a novel biomarker, which is a multi-copy gene present in A. phagocytophilum, and developing a diagnostic kit with specific primers and probes for PCR-based detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional PCR is used to detect A. phagocytophilum, then the detection method is simple, but the sensitivity is low because A. phagocytophilum is an intracellular bacterium
Solution Approach 1:
The patent changes the target parameter from single-copy genes (16S rRNA, ankA, groEL) to multi-copy genes (msp2/P44). This parameter change in gene copy number increases the amount of target DNA available for amplification, thereby improving detection sensitivity while maintaining the simplicity of conventional PCR methodology.
2Measurement precision
If nested PCR is performed twice to improve sensitivity, then the detection sensitivity increases, but the process becomes cumbersome and consumes more labor and time
Solution Approach 1:
The patent changes the target from single-copy to multi-copy genes, which provides sufficient amplification signal in a single PCR run. This eliminates the need for repeated nested PCR procedures, thereby maintaining high sensitivity while improving detection speed and reducing labor requirements.
Solution Approach 2:
The multi-copy nature of the msp2 gene provides excessive target material (more than sufficient copies) for a single PCR amplification, replacing the need for partial multiple amplification steps. This single-step approach achieves the same sensitivity as multiple nested PCRs but with greater efficiency.
3Measurement precision
If nested PCR is performed twice to improve sensitivity, then the detection sensitivity increases, but the potential for contamination increases
Solution Approach 1:
The patent changes the target parameter to multi-copy genes, which provides adequate amplification signal in a single PCR step. This reduces the number of opening and closing of tubes required, thereby minimizing opportunities for contamination while maintaining high detection sensitivity.
4Ease of operation
If serological tests are used for early detection, then the method is simple to perform, but the sensitivity is low because it takes several days for antibodies to form after symptom onset
Solution Approach 1:
The patent extracts the detection target from antibody responses (which require time to develop) to direct bacterial DNA detection using PCR. By targeting the bacterial genome itself rather than the host immune response, the method achieves early detection sensitivity without the time delay inherent in serological tests.
5Reliability
If culture methods are used to diagnose anaplasmosis, then the diagnosis can be definitive, but the culture time requires several weeks or more
Solution Approach 1:
The patent replaces the mechanical/biological culture process with a molecular amplification process (PCR). Instead of waiting for bacterial growth in culture media over weeks, the method uses enzymatic amplification of bacterial DNA to achieve definitive diagnosis in hours, maintaining reliability while dramatically reducing time loss.
Data Source
AI summary
A novel use of P44 as a marker for predicting or diagnosing anaplasmosis is disclosed. A diagnostic composition for anaplasmosis containing a P44 gene, a primer set or probe for detecting Anaplasma phagocytophilum, a kit for diagnosing anaplasmosis, and a method for providing information to diagnose infection with Anaplasma phagocytophilum are also disclosed. P44, which is a novel biomarker for diagnosing anaplasmosis, is a multi-copy gene and exists in a large number of copies in the Anaplasma phagocytophilum genome, thus having the effect of detecting Anaplasma phagocytophilum infection at high sensitivity using only a small amount of DNA compared to conventional diagnostic marker genes. In addition, the primer set or probe for detecting and amplifying P44 is capable of providing rapid and easy detection of anaplasmosis with high specificity and sensitivity, making it appropriate for early detection of anaplasmosis.